Cervical cancer screening in the Faroe Islands

References

• The World Bank. [Internet]. Washington, DC; GDP per capita (current US$). [cited 2014 Mar 24]. Available from: http://data.worldbank.org/indicator/NY.GDP.PCAP.CD/countries.
   Google Scholar
• Engholm G, Ferlay J, Christensen N, Johannesen TB, Khan S, Køtlum JE, et al. [Internet]. NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic countries, Version 6.0. Association of the Nordic Cancer Registries. Danish Cancer Society. [cited 2014 Apr 14]. Available from: http://www.ancr.nu.
   Google Scholar
• Linos A, Riza E, van Ballegooijen M. Cervical cancer screening in the European Union. Eur J Cancer 2000;36: 2175–275.
   PubMed Web of Science ®Google Scholar
• Ronco G, Anttila A. Cervical cancer screening in the Europe Union (Special Issue). Eur J Cancer 2009;45:2629–721.
   PubMed Web of Science ®Google Scholar
• Heilsuma lara ðið. Krabbameinsætlan fyri Føroyar 2009. [Internet]. Tórshavn; 2009 [cited 2013 Oct 16]. Available from: http://www.krabbamein.fo/Files/Filer/pdfar/Krabbameinsaetlan.pdf.
   Google Scholar
• Landssjúkrahúsið. Lívmóðurhálskrabbascreening – Cervix cancer screening. [Internet]. [cited 2013 Oct 19]. Available from: http://www.lsh.fo//Index.asp?pID = EC6931D8-7E96-4E18-BF4F-8BAC51C45F73.
   Google Scholar
• Sundhedsstyrelsen. Screening for livmoderhalskræft: Anbefalinger 2007. [Internet]. København; 2007 [cited 2013 Oct 20]. Available from: http://sundhedsstyrelsen.dk/publ/Publ2007/PLAN/Kraeft/Anbef_screen_livmoderhals.pdf.
   Google Scholar
• van den Brandt PA, Schouten LJ, Goldbohm RA, Dorant E, Hunen PM. Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol 1990;19:553–8.
   PubMed Web of Science ®Google Scholar
• van Ballegooijen M, van den Akker-van Marle E, Patnick J, Lynge E, Arbyn M, Anttila A, et al. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 2000;36:2177–88.
   PubMed Web of Science ®Google Scholar
• Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88–93.
   PubMed Web of Science ®Google Scholar
• Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: Systematic review and meta-analysis. Prev Med 2007;45:93–106.
   PubMed Web of Science ®Google Scholar
• Hakama M. Trends in the incidence of cervical cancer in the Nordic countries. In: Magnus K, editor. Trends in cancer incidence: Causes and practical implications. New York: Hemisphere; 1982. p. 279–92.
   Google Scholar
• Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. European guidelines for quality assurance in cervical cancer screening, 2nd ed–summary document. Ann Oncol 2010;21:448–58.
   PubMed Web of Science ®Google Scholar
• Ronco G, van Ballegooijen M, Becker N, Chil A, Fender M, Giubilato P, et al. Process performance of cervical screening programmes in Europe. Eur J Cancer 2009;45:2659–70.
   PubMed Web of Science ®Google Scholar
• Danish Cervical Cancer Screening Quality Assurance Data Base. Yearly report 2012. [Internet]. Aarhus; 2013 [cited 2013 Oct 15]. Available from: http://www.danskcytologiforening.dk/Rapporter/DKLS/DKLSaarsrapport2012.pdf.
   Google Scholar
• Rebolj M, van Ballegooijen M, Berkers LM, Habbema D. Monitoring a national cancer prevention program: Successful changes in cervical cancer screening in the Netherlands. Int J Cancer 2007;120:806–12.
   PubMed Web of Science ®Google Scholar
• Preisler S, Rebolj M, Untermann A, Ejegod DM, Lynge E, Rygaard C, et al. Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay. PLoS ONE 2013;8:e59765.
   PubMedGoogle Scholar
• Rask J, Lynge E, Franzmann M, Hansen B, Hjortebjerg A, Rygaard C, et al. Impact of technology on cytology outcome in cervical cancer screening of young and older women. Int J Cancer 2014;134:2168–79.
   PubMed Web of Science ®Google Scholar
• Dugue PA, Lynge E, Bjerregaard B, Rebolj M. Non-participation in screening: The case of cervical cancer in Denmark. Prev Med 2012;54:266–9.
   PubMed Web of Science ®Google Scholar
• Danielsen K, Hansen J, Mortensen G, Rubek Nielsen K, Sandberg Joensen D, Vedelsbøl A, et al. Det færøske screeningsprogram for livmoderhalskræft – elementer til en medicinsk teknologivurdering (Forskningstræningsprojekt). Landssjúkrahúsið: Tórshavn; 2009. Faroese.
   Google Scholar
• Gesink Law D, Rink E, Mulvad G, Koch A. Sexual health and sexually transmitted infections in the North American Arctic. Emerg Inf Dis 2008;14:4–9.
   PubMed Web of Science ®Google Scholar
• Sander BB, Rebolj M, Valentiner-Branth P, Lynge E. Introduction of human papillomavirus vaccination in Nordic countries. Vaccine 2012;30:1425–33.
   PubMed Web of Science ®Google Scholar